MoneyWorks4Me

RPG Life Sciences - Quaterly Results

19 Jul 2024 Evaluate
The revenue zoomed 11.94% to Rs. 1654.20 millions for the quarter ended June 2024 as compared to Rs. 1477.80 millions during the corresponding quarter last year.Profit saw a slight increase of 21.09%to Rs. 267.60  millions from Rs. 221.00 millions.Operating profit for the quarter ended June 2024 rose to 414.40 millions as compared to 340.50 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 1654.20 1477.80 11.94 1654.20 1477.80 11.94 5820.50 5128.10 13.50
Other Income 23.70 18.10 30.94 23.70 18.10 30.94 72.10 48.00 50.21
PBIDT 414.40 340.50 21.70 414.40 340.50 21.70 1353.60 1074.90 25.93
Interest 1.50 0.70 114.29 1.50 0.70 114.29 4.50 3.10 45.16
PBDT 412.90 339.80 21.51 412.90 339.80 21.51 1349.10 1071.80 25.87
Depreciation 52.90 42.10 25.65 52.90 42.10 25.65 170.70 155.00 10.13
PBT 360.00 297.70 20.93 360.00 297.70 20.93 1178.40 916.80 28.53
TAX 92.40 76.70 20.47 92.40 76.70 20.47 301.80 240.40 25.54
Deferred Tax -2.70 -2.50 8.00 -2.70 -2.50 8.00 -23.60 -3.10 661.29
PAT 267.60 221.00 21.09 267.60 221.00 21.09 876.60 676.40 29.60
Equity 132.30 132.30 0.00 132.30 132.30 0.00 132.30 132.30 0.00
PBIDTM(%) 25.05 23.04 8.73 25.05 23.04 8.73 23.26 20.96 10.95
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..